Morten Olesen

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 5

Top Topics

Atrial Fibrillation

Cross Sectional

Oral Anticoagulants

Top Venues

European heart journal

Clinical drug investigation

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Mikkel Hojlund, Lotte Rasmussen, Morten Olesen, Trine Munk-Olsen, Jesper Hallas
Who prescribes quetiapine in Denmark? British journal of clinical pharmacology 88 (9) (2022)
Joris J Komen, Jesper Hallas, Aukje K Mantel-Teeuwisse, Tomas Forslund, Paul Hjemdahl, Björn Wettermark, Nina Sahlertz Kristiansen, Morten Olesen, Marion Bennie, Tanja Mueller, Raymond Carragher, Øystein Karlstad, Lars Jøran Kjerpeseth, Olaf H Klungel
Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study. European heart journal 43 (37) (2022)
Elena Rivero-Ferrer, Morten Olesen, Estel Plana, Jaume Aguado, Nuria Saigi-Morgui, Annalisa Rubino, Sami Z Daoud, Alejhandra Lei, Susanna Perez-Gutthann, Nina Sahlertz Kristiansen, Nina Sahlertz Kristiansen, Jesper Hallas, Cristina Rebordosa, Cristina Rebordosa
Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany. Clinical drug investigation 42 (4) (2022)
Kasper Bruun Kristensen, Lars Christian Lund, Peter Bjødstrup Jensen, Anne Broe, Emelie Curovic Rotbain, Per Damkier, Jesper Hallas, Jacob Harbo Andersen, Mikkel Højlund, Morten Olesen, Lotte Rasmussen, Morten Rix Hansen, Martin Thomsen Ernst, Rikke Wesselhoeft, Daniel Pilsgaard Henriksen, Mette Reilev, Mette Bliddal, Nina Sahlertz Kristiansen
Development and Validation of a Nordic Multimorbidity Index Based on Hospital Diagnoses and Filled Prescriptions. Clinical epidemiology 14 (2022)
Veena Hoffman, Nina Sahlertz Kristiansen, Marie Linder, Andrea V Margulis, Brandon T Suehs, Alejandro Arana, Kelesitse Phiri, Cheryl Enger, Libby Horter, Ingvild Odsbu, Morten Olesen, Susanna Perez-Gutthann, Yihua Xu, Nina Sahlertz Kristiansen, Kwame Appenteng, Stefan de Vogel, John D Seeger, null null
Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study. Drug safety 44 (8) (2021)